Sponsor or institution

Clinical trials and research at Stemline Therapeutics, Inc.

• 6Clinical trials
• 19Countries

Newest trials

All recruiting trials (6)

• BPDCN patients treated with chemotherapy: a look back at real-world use

  This study tests how chemotherapy has performed in adults with BPDCN and compares the results to a prospective registry for ELZONRIS.

  Recruiting at 67 sites Stemline Therapeutics, Inc. · Aarhus and 66 other locations · NCT07785180

• Tagraxofusp in BPDCN: Real-world Registry of Safety and Effectiveness

  This registry follows adults with BPDCN to see how tagraxofusp works in everyday clinical practice and how safe it is over time.

  Recruiting at 41 sites Stemline Therapeutics, Inc. · Innsbruck and 40 other locations · NCT07785154

• Elacestrant Monotherapy in ER+/HER2- Advanced Breast Cancer with ESR1 Mutation (Japanese Participants)

  This study tests elacestrant alone to see if it helps Japanese adults with ER+/HER2- advanced or metastatic breast cancer that has ESR1 mutation and progressed after one or two prior endocrine therapies including a CDK4/6 inhibitor.

  Recruiting at 26 sites Phase 2 Stemline Therapeutics, Inc. · Chiba and 25 other locations · NCT07766018

• MEN2501 treatment for platinum-resistant ovarian cancer

  This trial tests a new drug called MEN2501 in adults whose ovarian cancer no longer responds to platinum chemotherapy.

  Recruiting at 15 sites Phase 1 Stemline Therapeutics, Inc. · Springdale, Arkansas and 14 other locations · NCT07226427

• Testing MEN2312 in adults with advanced breast cancer

  This study is testing a new drug called MEN2312 to see if it can help adults with advanced breast cancer that can't be cured, after they have already tried other treatments.

  Recruiting at 45 sites Phase 1 Stemline Therapeutics, Inc. · Springdale, Arkansas and 44 other locations · NCT06638307

• Combination treatment for brain metastasis from ER+/HER-2- breast cancer

  This study is testing a new combination treatment of elacestrant and abemaciclib to see if it can help people with brain metastases from estrogen receptor-positive, HER-2 negative breast cancer.

  Recruiting at 78 sites Phase 1/2 Stemline Therapeutics, Inc. · Fullerton, California and 85 other locations · NCT05386108

Quick answers

How many clinical trials run by Stemline Therapeutics, Inc. are recruiting right now?

6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 19 countries. The most sites are in Spain (4 trials), Germany (3 trials), Italy (3 trials), United States (3 trials), France (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 2, Phase 1/2: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →